Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ · Healthcare
Recursion Pharmaceuticals, Inc. Cash on Hand 2019–2025
Recursion Pharmaceuticals, Inc. annual/quarterly cash on hand history from 2020 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Recursion Pharmaceuticals, Inc. cash on hand for the quarter ending December 31, 2025 were 743.3M, a 25.06% increase year-over-year.
- Recursion Pharmaceuticals, Inc. cash on hand for 2025 were 743.3M, a 25.06% increase from 2024.
- Recursion Pharmaceuticals, Inc. cash on hand for 2024 were 594.4M, a 51.79% increase from 2023.
- Recursion Pharmaceuticals, Inc. cash on hand for 2023 were 391.6M, a 28.79% decrease from 2022.
- Recursion Pharmaceuticals, Inc. cash on hand for 2022 were 549.9M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Recursion Pharmaceuticals, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $743 |
| 2024 | $594 |
| 2023 | $392 |
| 2022 | $550 |
| 2021 | $285 |
| 2020 | $262 |
| Recursion Pharmaceuticals, Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $743 |
| 2024-12-31 | $594 |
| 2023-12-31 | $392 |
| 2022-12-31 | $550 |
| 2021-12-31 | $285 |
| 2020-12-31 | $262 |
Recursion Pharmaceuticals, Inc. Cash on Hand — FAQ
Recursion Pharmaceuticals, Inc. (RXRX) cash on hand over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RXRX's cash on hand history?
The chart and table above show Recursion Pharmaceuticals, Inc.'s cash on hand by year and by quarter, including the growth rate.